Kalra, Sanjay http://orcid.org/0000-0003-1308-121X
Anjana, Ranjit Mohan http://orcid.org/0000-0002-4843-1374
Verma, Madhur http://orcid.org/0000-0002-1787-8392
Pradeepa, Rajendra http://orcid.org/0000-0002-4909-3733
Sharma, Nikita
Deepa, Mohan http://orcid.org/0000-0001-6348-1946
Singh, Omna
Venkatesan, Ulagamadesan http://orcid.org/0000-0002-1638-6046
Elangovan, Nirmal
Aggarwal, Sameer
Kakkar, Rakesh
Mohan, Viswanathan http://orcid.org/0000-0001-5038-6210
Article History
Received: 9 January 2024
Accepted: 1 May 2024
First Online: 21 May 2024
Declarations
:
: Sanjay Kalra is an Editorial Board member of <i>Diabetes Therapy</i>. Sanjay Kalra was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. The other authors (Ranjit Mohan Anjana, Madhur Verma, Rajendra Pradeepa, Nikita Sharma, Mohan Deepa, Omna Singh, Ulagamadesan Venkatesan, Nirmal Elangovan, Sameer Aggarwal, Rakesh Kakkar and Viswanathan Mohan) have nothing to disclose.
: The study was ethically approved by the Institutional Ethics Committee of Madras Diabetes Research Foundation vide letter number MDRF/NCT/02–08/2018, dated 2 March 2018. Informed consent was obtained from all the participants before the interview was initiated, and their blood samples were drawn. Participants with abnormal biochemical profiles were ensured a standard of care by linking them to the nearest government health centre per pre-defined protocols. This study was conducted in accordance with the Helsinki Declaration of 1964 and its later amendments.